EDGAR Filing Documents for 0001193805-17-000216

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

SEC Accession No. 0001193805-17-000216

Filing Date

2017-02-14

Accepted

2017-02-14 12:40:12

Documents

Group Members

DEERFIELD INTERNATIONAL MASTER FUND, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD PRIVATE DESIGN FUND II, L.P.DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.DEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq	Description	Document	Type	Size
1		e615762_sc13ga-horizon.htm	SC 13G/A	354448
	Complete submission text file	0001193805-17-000216.txt		356191

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017

Business Address

Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A

Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4

Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100

Horizon Pharma plc (Subject) CIK: 0001492426 (see all company filings)